No Data
No Data
No Data
No Data
No Data
Hyperfine Announced The Acceptance Of Seventeen Ultra-low-field MRI-related Abstracts To Be Presented At The 2024 International Society For Magnetic Resonance In Medicine Annual Meeting In Singapore
Hyperfine Announced The Acceptance Of Seventeen Ultra-low-field MRI-related Abstracts To Be Presented At The 2024 International Society For Magnetic Resonance In Medicine Annual Meeting In Singapore
BenzingaApr 23 09:06 ET
Hyperfine, Inc. Takes the Stage at ISMRM With Seventeen Abstracts Assessing the Potential of Using Swoop System Images Across Multiple Care Settings and Clinical Conditions
Data on the company's portable MR imaging system show it can acquire brain images at the point of care that may assist physicians with screening and monitoring for Alzheimer's and multiple sclerosis b
BusinesswireApr 23 09:00 ET
Express News | Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in Care Pmr Study
Moomoo 24/7Apr 17 09:00 ET
Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop system—today announced that the first patients have been enrolled in the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) observational study.
BusinesswireApr 17 09:00 ET
SEC Baby Shelf Rules Stunt Hyperfine Inc.'s Fundraising Flexibility
TipRanksMar 24 02:02 ET
Hyperfine Price Target Cut to $1.60/Share From $2.10 by Wells Fargo
Hyperfine Price Target Cut to $1.60/Share From $2.10 by Wells Fargo
Dow JonesMar 22 11:34 ET
No Data
No Data